Sun Pharma Advanced Research Company Limited (SPARC) - Total Assets

Latest as of September 2025: Rs3.22 Billion INR ≈ $34.87 Million USD

Based on the latest financial reports, Sun Pharma Advanced Research Company Limited (SPARC) holds total assets worth Rs3.22 Billion INR (≈ $34.87 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See SPARC book value for net asset value and shareholders' equity analysis.

Sun Pharma Advanced Research Company Limited - Total Assets Trend (2007–2025)

This chart illustrates how Sun Pharma Advanced Research Company Limited's total assets have evolved over time, based on quarterly financial data.

Sun Pharma Advanced Research Company Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Sun Pharma Advanced Research Company Limited's total assets of Rs3.22 Billion consist of 7.8% current assets and 92.2% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	0.6%
Accounts Receivable	Rs160.60 Million	4.8%
Inventory	Rs19.54 Million	0.6%
Property, Plant & Equipment	Rs992.55 Million	29.6%
Intangible Assets	Rs536.50 Million	16.0%
Goodwill	Rs0.00	0.0%

Asset Composition Trend (2007–2025)

This chart illustrates how Sun Pharma Advanced Research Company Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see SPARC stock market capitalisation.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Sun Pharma Advanced Research Company Limited's current assets represent 7.8% of total assets in 2025, a decrease from 45.8% in 2007.
Cash Position: Cash and equivalents constituted 0.6% of total assets in 2025, up from 0.0% in 2007.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 15.0% of total assets, an increase from 0.0% in 2007.
Asset Diversification: The largest asset category is property, plant & equipment at 29.6% of total assets.

Sun Pharma Advanced Research Company Limited Competitors by Total Assets

Key competitors of Sun Pharma Advanced Research Company Limited based on total assets are shown below.

Company	Country	Total Assets
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥31.46 Billion
Yuhan Corp. KO:000100	Korea	₩3.05 Trillion
Tasly Pharmaceutical Group Co Ltd SHG:600535	China	CN¥15.34 Billion
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	China	CN¥15.32 Billion
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	China	CN¥10.96 Billion
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	China	CN¥1.54 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion
Cronos Group Inc TO:CRON	Canada	CA$1.18 Billion

Sun Pharma Advanced Research Company Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	0.03	0.32	0.28
Quick Ratio	0.03	0.32	0.28
Cash Ratio	0.00	0.00	0.00
Working Capital	Rs-4.77 Billion	Rs-1.88 Billion	Rs-1.74 Billion

Sun Pharma Advanced Research Company Limited - Advanced Valuation Insights

This section examines the relationship between Sun Pharma Advanced Research Company Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	56.32
Latest Market Cap to Assets Ratio	0.15
Asset Growth Rate (YoY)	-34.9%
Total Assets	Rs3.36 Billion
Market Capitalization	$502.01 Million USD

Valuation Analysis

Below Book Valuation: The market values Sun Pharma Advanced Research Company Limited's assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Sun Pharma Advanced Research Company Limited's assets decreased by 34.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Sun Pharma Advanced Research Company Limited (2007–2025)

The table below shows the annual total assets of Sun Pharma Advanced Research Company Limited from 2007 to 2025.

Year	Total Assets	Change
2025-03-31	Rs3.36 Billion ≈ $36.29 Million	-34.85%
2024-03-31	Rs5.15 Billion ≈ $55.70 Million	-37.96%
2023-03-31	Rs8.30 Billion ≈ $89.77 Million	+196.38%
2022-03-31	Rs2.80 Billion ≈ $30.29 Million	+21.94%
2021-03-31	Rs2.30 Billion ≈ $24.84 Million	-15.73%
2020-03-31	Rs2.73 Billion ≈ $29.48 Million	-31.60%
2019-03-31	Rs3.98 Billion ≈ $43.09 Million	+29.04%
2018-03-31	Rs3.09 Billion ≈ $33.40 Million	+12.69%
2017-03-31	Rs2.74 Billion ≈ $29.64 Million	+68.47%
2016-03-31	Rs1.63 Billion ≈ $17.59 Million	+14.01%
2015-03-31	Rs1.43 Billion ≈ $15.43 Million	-22.27%
2014-03-31	Rs1.84 Billion ≈ $19.85 Million	-12.18%
2013-03-31	Rs2.09 Billion ≈ $22.60 Million	+144.08%
2012-03-31	Rs856.26 Million ≈ $9.26 Million	+10.49%
2011-03-31	Rs774.98 Million ≈ $8.38 Million	+7.28%
2010-03-31	Rs722.39 Million ≈ $7.81 Million	+17.36%
2009-03-31	Rs615.53 Million ≈ $6.66 Million	+0.07%
2008-03-31	Rs615.09 Million ≈ $6.65 Million	+11.31%
2007-03-31	Rs552.58 Million ≈ $5.98 Million	--

About Sun Pharma Advanced Research Company Limited

NSE:SPARC India Drug Manufacturers - Specialty & Generic

Market Cap

$502.01 Million

Rs46.42 Billion INR

Market Cap Rank

#12516 Global

#593 in India

Share Price

Rs143.04

Change (1 day)

-3.72%

52-Week Range

Rs108.71 - Rs198.54

All Time High

Rs519.35